2023-03-24 07:18:21 ET
- Purple Biotech ( NASDAQ: PPBT ) on Friday said that the CEO, Gil Efron, has been hospitalized following a mishap and will be on medical leave , which is expected to last several months while he undergoes rehabilitation to recover from his injuries.
- The board appoints Isaac Israel, a current board member and the former CEO, to serve as acting CEO during Gil Efron’s absence.
- The company’s business plan and clinical development programs continue as planned .
For further details see:
Purple Biotech CEO Gil Efron takes medical leave, Isaac Israel named acting CEO